Sc Sigmedical Srl

Suceava 720214

2 studies enrolling now · 2 studies all time

What they study most

Cancer, Gastric Cancer, Gastroesophageal-junction Cancer, HER2-positive Gastric Cancer, Monoclonal Antibody

Studies at this site

• Pan Tumor Rollover Study — Recruiting now
• A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer — Recruiting now